Is there a role for any non-cisplatin based adjuvant therapy or radiotherapy (in absence of platinum sensitizer) for muscle-invasive, node-negative bladder cancer after radical cystectomy?

Topics: Genitourinary Cancers • Medical Oncology

The patient is cisplatin ineligible due to renal dysfunction.

Answer from: Medical Oncologist at Academic Institution

This is a very clinically relevant question that we often wrestle with the optimal management. In the adjuvant space, multiple investigators have looked at alternative adjuvant chemotherapy regimens for patients after cystectomy and deemed cisplatin-ineligible. The most ideal would be carboplatin-b...

Comments

Medical Oncologist at Memorial Sloan Kettering Cancer Center
Thank you for the explanation Dr Mendiratta. This ...

Medical Oncologist at University of Washington School of Medicine
I agree with @Prateek Mendiratta, there is current...

Related Questions